Targeting Molecules Involved in Immune Cell Trafficking to the Central Nervous System for Therapy in Multiple Sclerosis

Clinical and Experimental Neuroimmunology - United Kingdom
doi 10.1111/cen3.12399
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Central Nervous System B-Cell Lymphoma in Multiple Sclerosis

Turkish Neurosurgery
SurgeryNeurology
2010English

Cell Therapy for Central Nervous System Disorders: Current Obstacles to Progress

CNS Neuroscience and Therapeutics
PsychiatryMental HealthPhysiologyPharmacology
2019English

The Role of Dopamine in Regulating Interactions of the Immune and Nervous System in Multiple Sclerosis

Journal of the Neurological Sciences
Neurology
2015English

Investigating the Antigen Specificity of Multiple Sclerosis Central Nervous System-Derived Immunoglobulins

Frontiers in Immunology
AllergyImmunology
2015English

Physical Therapy for Central Nervous System in the Elderly.

Rigakuryoho Kagaku
Physical TherapySports TherapyRehabilitation
2002English

Marizomib for Central Nervous System-Multiple Myeloma

British Journal of Haematology
Hematology
2017English

Advances in Progenitor Cell Therapy Using Scaffolding Constructs for Central Nervous System Injury

Stem Cell Reviews and Reports
2009English

Expression of Specific Chemokines and Chemokine Receptors in the Central Nervous System of Multiple Sclerosis Patients

Journal of Clinical Investigation
Medicine
1999English

Naturally Presented Peptides on Major Histocompatibility Complex I and II Molecules Eluted From Central Nervous System of Multiple Sclerosis Patients

Molecular and Cellular Proteomics
BiochemistryMedicineAnalytical ChemistryMolecular Biology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy